DAT
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| FB00876 | Vanoxerine | 67469-69-6 | Vanoxerine is a potent and selective DRI (dopamine reuptake inhibitor). |
| FB03839 | Vanoxerine 2HCl | 67469-78-7 | Vanoxerine 2HCl is a selcetive and potent Dopamine reuptake inhibitor (DRI). |
| FB17601 | SKF-83566 | 99295-33-7 | SKF-83566 is a potent, blood-brain permeable and orally active dopamine D1/D5 receptor antagonist . SKF-83566 is a competitive DAT (dopamine transporter) inhibitor with an IC50 of 5.7 μM and attenuates cocaine effects in vivo . |
| FB10854 | Liafensine | 1198790-53-2 | Liafensine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) which is under development for the treatment of major depressive disorder. |
| FB07431 | GBR 12935 Maleate | 1349767-56-1 | GBR 12935 is a potent, and selective dopamine reuptake inhibitor. |
| FB19623 | GBR 12935 | 76778-22-8 | GBR 12935 is a potent, and selective dopamine reuptake inhibitor. |
| FB09669 | GBR 12935 2HCl | 67469-81-2 | GBR 12935 2HCl is a potent and selective dopamine reuptake inhibitor with KD of 5.5 nM in rat striatal membranes. |
| FB00436 | Diclofensine | 67165-56-4 | Diclofensine is a potent inhibitor of monoamine reuptake, blocking the uptake of dopamine, noradrenaline, and serotonin by rat brain synaptosomes with IC50 values of 0.74, 2.3, and 3.7 nM, respectively. |
| FB07432 | Diclofensine HCl | 34041-84-4 | Diclofensine is a potent inhibitor of monoamine reuptake, blocking the uptake of dopamine, noradrenaline, and serotonin by rat brain synaptosomes with IC50 values of 0.74, 2.3, and 3.7 nM, respectively. |
| FB10462 | Bupropion HCl | 31677-93-7 | Bupropion HCl, a unicyclic, aminoketone antidepressant, is a selective norepinephrine-dopamine reuptake inhibitor with IC50 of 6.5 and 3.4 μM for the reuptake of dopamine and norepinephrine, respectively. |
| FB07648 | Amineptine | 57574-09-1 | Amineptine is a tricyclic antidepressant drug selectively blocking dopamine uptake, on 3H-imipramine binding, which was investigated in platelets of major depressed patients in conjunction with changes in clinical state. |